Natalie C. Holles - 14 Sep 2022 Form 3 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role: CEO, Director
Signature: /s/ Natalie Holles
Issuer symbol: THRD
Transactions as of: 14 Sep 2022
Net transactions value: $0
Form type: 3
Filing time: 14 Sep 2022, 18:10:25 UTC
Previous filing: 23 Jun 2022
Next filing: 27 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	THRD	Common Stock						1,218,836	14 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	THRD	Employee Stock Option (right to buy)							14 Sep 2022	Common Stock	467,634	$9.22	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Certain amount of the shares are subject to forfeiture.
F2	6.25% of the total shares vested on May 17, 2022, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.